Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131620) titled 'Evaluate the efficacy and safety of Lactobacillus jensenii in the management of female perimenopausal syndrome' on Sept. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Nanchang Reproductive Hospital
Condition:
Perimenopausal Syndrome
Intervention:
Intervention Group:Lactobacillus johnsonii
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-07
Target Sample Size: Intervention Group:50;Control Group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341269
Published by HT Digital Content Serv...